8-KThe WireRoutine
Shareholder Vote
Filed Nov 18, 2024 · 1y ago · Accession 0001213900-24-099645
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Nov 18, 2024
- Report date
- Nov 14, 2024
- Document
- ea0221692-8k_oruka.htm
- Size
- 195 KB